Contents: Vemurafenib
Indications: Treatment of unresectable or metastatic melanoma patients with BRAF V600 mutation.
Administration: May be taken with or without food: Swallow whole, do not chew/crush.
Adverse Drug Reactions: Rash, photosensitivity reaction, alopecia, pruritis, hyperkeratosis, arthralgia, fatigue, nausea, diarrhea, headache, skin papilloma, cutaneous squamous cell carcinoma.
Regulatory Classification: Rx
Manufacturer: Roche
Distributor: Zuellig
